NeoPhore
Series BCambridge, UKJan 2023
NeoPhore raised €6.8M in a Series B round in Jan 2023. The company is based in Cambridge, UK. Investors in the round: 2Invest, 3B Future Health Fund, Astellas Venture Management and 2 others. Data as of 4 Nov 2026.
Amount raised
€6.8M
€6,845,564
Native amount
6,000,000 GBP
Stage
Series B
series b
Investors
5
Provenance & confidence
Low confidenceAmount
6,000,000 GBP
ECB-at-date → €6.8M · rate 0.87648 on 2023-01-19
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Jan 2023
Round type
series b
Amount (EUR)
€6.8M